Femasys (FEMY) Net Shares Issued and Repurchased (2020 - 2026)
Femasys' (FEMY) quarterly Net Shares Issued and Repurchased came in at $623322.0 in Q1 2026, up 523.32% on a YoY basis from $100000.0 in Q1 2025, and down 61.99% quarter-over-quarter from $1.6 million in Q4 2025.
Analysis
Femasys (FEMY) Net Shares Issued and Repurchased (2020 - 2026) Analysis & Trends
Femasys (FEMY) has reported Net Shares Issued and Repurchased for 7 consecutive years, with $623322.0 the latest figure, recorded in Q1 2026.
- For the quarter ending Q1 2026, Net Shares Issued and Repurchased rose 523.32% year-over-year to $623322.0; the trailing twelve-month figure through Mar 2026 stood at $623322.0 (up 523.32% YoY), and the FY2025 full-year result was $1.6 million, up 20.6% from the prior year.
- Net Shares Issued and Repurchased slipped to $623322.0 in Q1 2026 per FEMY's latest filing, from $1.6 million in the prior quarter.
- Across five years, Net Shares Issued and Repurchased topped out at $1.6 million in Q4 2025 and bottomed at $34300.0 in Q3 2022.
- Historically, Net Shares Issued and Repurchased has averaged $558876.7 across 5 years, with a median of $318920.0 in 2022.
- The sharpest annual moves came in 2022 and 2025: Net Shares Issued and Repurchased soared 4288.52% in 2022, then slumped 85.89% in 2025.
- Over 5 years, Net Shares Issued and Repurchased stood at $367670.0 in 2022, then soared by 253.9% to $1.3 million in 2023, then increased by 4.51% to $1.4 million in 2024, then rose by 20.6% to $1.6 million in 2025, then sank by 61.99% to $623322.0 in 2026.
- According to Business Quant data, Net Shares Issued and Repurchased over the past three periods registered $623322.0, $1.6 million, and $100000.0 for Q1 2026, Q4 2025, and Q2 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | - |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | - |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | - |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | - |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | - |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | - |
| 10 | Femasys | 9.01 Mn | 7.57 Mn | 189,391.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 623,322.00 |
| Dec 31, 2025 | 1.64 Mn |
| Jun 30, 2025 | 100,000.00 |
| Mar 31, 2025 | 100,000.00 |
| Dec 31, 2024 | 1.36 Mn |
| Mar 31, 2024 | 708,821.00 |
| Dec 31, 2023 | 1.30 Mn |
| Sep 30, 2023 | 1.06 Mn |
| Jun 30, 2023 | 153,200.00 |
| Mar 31, 2023 | 50,055.00 |
| Dec 31, 2022 | 367,670.00 |
| Sep 30, 2022 | 34,300.00 |
| Jun 30, 2022 | 51,000.00 |
| Mar 31, 2022 | 270,170.00 |
| Dec 31, 2021 | 8,378.00 |
| Dec 31, 2020 | 187,206.00 |